Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Tag Archives: China
Working Towards a Solution : An Interview with Oracle’s Neil de Crescenzo
Just a few days shy of the one year anniversary of the launch of Oracle’s Health Sciences Global Business Unit, Neil de Crescenzo, senior vice president and general manager for the business unit sat down with Pharm Exec to talk about the future of clinical trial software and technology and the need for standards and [...]
Posted in People, Strategy, Technology Also tagged cloud computing, hosted applications, india, IT, Oracle, pharmerging markets, software, Technology 2 Comments
The Real China Strategy
There’s a lot of talk these days about India and China as potential markets and as sources for cheap manufacturing and R&D. But the real potential of these countries is far more interesting: As China and India (and Brazil, Russia, and Korea) learn to create new products, they’re going to do it at price [...]
Posted in Biotech, Deals, Emerging Markets, Strategy Also tagged Abe Abuchowski, Biotech, PEGylation, Pharma, Prolong 8 Comments

US and Europe At Risk from Substandard Medicines